• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面活性剂在呼吸窘迫综合征中的作用。

Surfactant function in respiratory distress syndrome.

作者信息

Ikegami M, Jacobs H, Jobe A

出版信息

J Pediatr. 1983 Mar;102(3):443-7. doi: 10.1016/s0022-3476(83)80673-8.

DOI:10.1016/s0022-3476(83)80673-8
PMID:6687477
Abstract

Airway samples from infants with respiratory distress syndrome were recovered by suction immediately after tracheal intubation for respiratory failure. The minimum surface tension of these airway samples was 27.3 +/- 3.0 dynes/cm. Surfactant with low surface tension (1.4 +/- 1.0 dynes/cm) was recovered from these samples by centrifugation; the supernatant fractions from the samples had high minimum surface tensions. The supernatant fractions contained soluble proteins that inhibited the surface tension-lowering properties of natural sheep surfactant. Similar supernatant fractions collected from infants intubated for reasons other than respiratory distress syndrome were much less inhibitory to sheep surfactant. The minimum surface tension of sequential daily airway samples from infants with respiratory distress syndrome fell progressively to 5.7 +/- 2.4 dynes/cm on the day of extubation. These results document the presence of proteins in the airways of infants with respiratory distress syndrome that inhibit the surface tension-lowering properties of surfactant.

摘要

因呼吸衰竭行气管插管后,立即通过吸引获取患有呼吸窘迫综合征婴儿的气道样本。这些气道样本的最小表面张力为27.3±3.0达因/厘米。通过离心从这些样本中回收了具有低表面张力(1.4±1.0达因/厘米)的表面活性剂;样本的上清液部分具有较高的最小表面张力。上清液部分含有可抑制天然绵羊表面活性剂降低表面张力特性的可溶性蛋白质。从因呼吸窘迫综合征以外的原因插管的婴儿中收集的类似上清液部分对绵羊表面活性剂的抑制作用要小得多。患有呼吸窘迫综合征婴儿的连续每日气道样本的最小表面张力在拔管当天逐渐降至5.7±2.4达因/厘米。这些结果证明了患有呼吸窘迫综合征的婴儿气道中存在抑制表面活性剂降低表面张力特性的蛋白质。

相似文献

1
Surfactant function in respiratory distress syndrome.表面活性剂在呼吸窘迫综合征中的作用。
J Pediatr. 1983 Mar;102(3):443-7. doi: 10.1016/s0022-3476(83)80673-8.
2
Phospholipids in tracheal effluent from infants with severe respiratory distress syndrome.患有严重呼吸窘迫综合征的婴儿气管流出物中的磷脂
Am J Perinatol. 1984 Apr;1(3):208-13. doi: 10.1055/s-2007-1000006.
3
Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia.患有呼吸窘迫综合征并发展为支气管肺发育不良的早产儿的表面活性物质磷脂与表面活性
Acta Paediatr. 2000 Oct;89(10):1218-25. doi: 10.1080/080352500750027600.
4
A protein that inhibits surfactant in respiratory distress syndrome.
Biol Neonate. 1986;50(3):121-9. doi: 10.1159/000242588.
5
Respiratory distress syndrome in very low birth weigh infants with occasionally normal surfactant phospholipids.极低出生体重儿呼吸窘迫综合征,偶尔伴有正常的表面活性物质磷脂。
Eur J Pediatr. 1982 Sep;139(1):31-4. doi: 10.1007/BF00442075.
6
Surfactant pool sizes and severity of respiratory distress syndrome in prematurely delivered lambs.早产羔羊的表面活性物质池大小与呼吸窘迫综合征的严重程度
Am Rev Respir Dis. 1983 Jun;127(6):751-5. doi: 10.1164/arrd.1983.127.6.751.
7
Sequential treatments of premature lambs with an artificial surfactant and natural surfactant.用人工表面活性剂和天然表面活性剂对早产羔羊进行序贯治疗。
J Clin Invest. 1981 Aug;68(2):491-6. doi: 10.1172/jci110280.
8
Comparison of four surfactants: in vitro surface properties and responses of preterm lambs to treatment at birth.
Pediatrics. 1987 Jan;79(1):38-46.
9
Premature lambs rescued from respiratory failure with natural surfactant: clinical and biophysical correlates.用天然表面活性剂挽救呼吸衰竭的早产羔羊:临床与生物物理相关性
Pediatr Res. 1982 Jun;16(6):424-9. doi: 10.1203/00006450-198206000-00005.
10
Lung surfactant phospholipids in the foetus, newborn, and in the adult; evidence of abnormality in respiratory failure.胎儿、新生儿及成人肺表面活性物质磷脂;呼吸衰竭时异常的证据
Ann Chir Gynaecol Suppl. 1982;196:19-23.

引用本文的文献

1
Respiratory distress syndrome is the poster child for neonatology.呼吸窘迫综合征是新生儿学的典型病例。
Pediatr Res. 2025 Jan 16. doi: 10.1038/s41390-024-03723-1.
2
Alan Jobe's legendary career.艾伦·乔布的传奇职业生涯。
Pediatr Res. 2023 Sep;94(3):1245-1247. doi: 10.1038/s41390-023-02678-z. Epub 2023 Jun 6.
3
Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider.动脉导管未闭:儿科和成人心脏护理提供者的当代视角。
J Am Heart Assoc. 2022 Sep 6;11(17):e025784. doi: 10.1161/JAHA.122.025784. Epub 2022 Sep 3.
4
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure.重新审视肺表面活性剂在慢性炎症性肺疾病和环境暴露中的作用。
Eur Respir Rev. 2021 Dec 15;30(162). doi: 10.1183/16000617.0077-2021. Print 2021 Dec 31.
5
Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature Infants.房间隔缺损与早产儿支气管肺发育不良的相关性。
J Pediatr. 2018 Nov;202:56-62.e2. doi: 10.1016/j.jpeds.2018.07.024. Epub 2018 Aug 29.
6
Surface tension in human pathophysiology and its application as a medical diagnostic tool.表面张力在人类病理生理学中的应用及其作为医学诊断工具的应用。
Bioimpacts. 2015;5(1):29-44. doi: 10.15171/bi.2015.06. Epub 2015 Feb 28.
7
The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.动脉导管未闭及其治疗在支气管肺发育不良中的作用。
Semin Perinatol. 2013 Apr;37(2):102-7. doi: 10.1053/j.semperi.2013.01.006.
8
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.早期与延迟选择性表面活性剂治疗新生儿呼吸窘迫综合征
Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD001456. doi: 10.1002/14651858.CD001456.pub2.
9
SP-B and SP-C containing new synthetic surfactant for treatment of extremely immature lamb lung.含 SP-B 和 SP-C 的新型合成表面活性剂治疗极不成熟羔羊肺。
PLoS One. 2012;7(7):e39392. doi: 10.1371/journal.pone.0039392. Epub 2012 Jul 13.
10
Prophylactic administration of surfactant in extremely premature infants.对极早产儿预防性给予表面活性剂。
Crit Care Res Pract. 2010;2010. doi: 10.1155/2010/235894. Epub 2010 Jun 7.